Category Archives: Pr Newswire

Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to September 3, 2024

New York, Aug. 05, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose acquisition company, announced today that on August 2, 2024, its sponsor, Vision Sensing, LLC, deposited $51,016.10 into the Company’s trust account, which is the sum that the Company must pay to extend the date […]

Everest Medicines to Announce 2024 Interim Results on August 28, 2024

SHANGHAI, Aug. 6, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that it will report its interim results for the six months ended June 30, 2024, and provide a business update on August 28, 2024. […]

CrowdProperty Australia Investment Trust receives favourable rating from SQM Research

SYDNEY, Aug. 6, 2024 /PRNewswire/ — CrowdProperty Australia’s real estate debt investment fund has achieved a ‘favourable’ 3.75-star rating from SQM Research. This rating signifies the fund’s “moderate potential to outperform over the medium-to-long term” and makes it a strong candidate for inclusion on most approved product lists (APLs). In awarding a 3.75-star ‘favourable’ rating, the […]

OutSystems Celebrates Decade-Long Digital Transformation Journey with Toyota Motor Corporation

23 Toyota Group companies adopt OutSystems as their enterprise low-code application development platform  SINGAPORE, Aug. 6, 2024 /PRNewswire/ — OutSystems, a global leader transforming how companies innovate through software, today celebrates ten years of successful digital transformation with Toyota Motor Corporation, one of the world’s leading automakers. This partnership with OutSystems is a cornerstone of […]

Ricoh Achieves ‘Gold Provider’ Partner Status with CISCO in the Asia-Pacific Region

TOKYO, Aug. 6, 2024 /PRNewswire/ — Ricoh and its affiliates have been awarded the esteemed ‘Gold Provider’ Partner status in the Asia-Pacific region by Cisco, a worldwide leader in networking and security, marking a new chapter in the long-standing partnership between the two companies. This accolade, which was awarded following a comprehensive evaluation, where Ricoh […]

AeC Awarded Frost & Sullivan’s 2024 Brazil Company of the Year Award for Its Exceptional Customer Experience Management Solutions

AeC delivers top-notch customer experience (CX) services, enhances productivity, and fosters a customer-centric approach in the Brazilian industry by leveraging its highly advanced CX management (CXM) tools. SAN ANTONIO, Aug. 6, 2024 /PRNewswire/ — Frost & Sullivan recently researched the CXM industry and, based on its findings, recognizes AeC with the 2024 Brazil Company of the Year Award. […]

TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team

TAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) — TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced the appointment of Narasimhan Mani, Ph.D., MBA as Scienture’s President. Shankar Hariharan, Ph.D., the current President and CEO, will be CEO of Scienture. Rahul Surana, Ph.D., […]

Mesa Labs Announces First Quarter Results

LAKEWOOD, Colo., Aug. 05, 2024 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter (“1Q25”) ended June 30, 2024 (amounts in thousands). First quarter FY 2025 compared to first quarter FY 2024: […]

Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio

Friedreich Ataxia (FA) and Fuchs Endothelial Corneal Dystrophy (FECD) Programs on Track and Advancing Toward Clinical Trials Active Research Pipeline with Programs Progressing in Myotonic Dystrophy Type-1 (DM1) and Huntington’s Disease (HD) Cash and Securities of $261.0 Million Supports Operations Through Potentially Four Clinical Proof-of-Concept Data Sets CARLSBAD, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) — […]

4DMT Advances Leadership in Large Market Ophthalmology with Senior Management Hires and Formation of Ophthalmology Advisory Board

Dhaval Desai, PharmD, named as Chief Development Officer; will oversee late-stage Product Development, Medical Affairs, Scientific Communications, Regulatory and Quality operations; most recently SVP & Chief Development Officer at Iveric Bio where he led development and approval of IZERVAY Christopher Simms named as Chief Commercial Officer, effective September 25, 2024; will oversee Pre-commercial and Commercial […]